首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material.
【24h】

International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material.

机译:国际临床化学联合会用于测量载脂蛋白A-I和B的标准化项目。通过使用国际参考资料可比较载脂蛋白A-I值。

获取原文
           

摘要

In the third phase of the International Federation of Clinical Chemistry (IFCC) study for the standardization of apolipoprotein (apo) measurements, the preparation SP1-01, selected as the candidate international reference material for apo A-I, was investigated for its ability to transfer an accuracy-based value to the immunoassay calibrators and to produce comparability of the values for patients' samples. An apo A-I value of 1.50 g/L (SD 0.08 g/L) was assigned to SP1-01 by a highly standardized RIA calibrated with purified apo A-I for which the mass value had been determined by amino acid analysis. According to a common detailed protocol, the participants transferred the mass value from SP1-01 to the calibrator of each method. To confirm that uniformity of calibration ensures comparability of the values over a wide range of apo A-I values, each laboratory analyzed 50 fresh-frozen samples from individual donors, using an approach similar to that adopted by the Cholesterol Reference Laboratory Network. The consensus mean value for each sample was in excellent agreement with the value assigned by the Northwest Lipid Research Laboratories, with the average absolute bias between assigned and consensus value being 0.01 g/L. The among-laboratory CV on each of the 50 samples ranged from 2.1% to 5.6% (mean 3.6%), demonstrating that comparable apo A-I results can be obtained by a variety of immunochemical methods through the use of certified reference material. Based on the results obtained in these studies, SP1-01 has been approved as Apolipoprotein A-I International Reference Material by the World Health Organization.
机译:在国际临床化学联合会(IFCC)进行的载脂蛋白(apo)测量标准化研究的第三阶段,研究了SP1-01制剂被选为载脂蛋白AI的候选国际参考材料,它具有转移载脂蛋白的能力。基于准确度的值到免疫测定校准物,并产生患者样品值的可比性。通过用纯化的载脂蛋白A-I校准的高度标准化的RIA,将1.50 g / L的载脂蛋白A-I值(标准差0.08 g / L)分配给SP1-01,其质量值已通过氨基酸分析确定。根据通用的详细协议,参与者将质量值从SP1-01传递到每种方法的校准器。为了确认校准的统一性确保在广泛的Apo A-I值之间具有可比性,每个实验室使用类似于胆固醇参考实验室网络采用的方法分析了来自各个供体的50个新鲜冷冻样品。每个样品的共识平均值与西北脂质研究实验室分配的值非常吻合,分配和共识值之间的平均绝对偏差为0.01 g / L。 50个样本中每个样本的实验室间CV范围在2.1%至5.6%(平均3.6%)之间,表明可通过多种免疫化学方法通过使用认证的参考材料获得可比的apo A-I结果。根据这些研究中获得的结果,SP1-01已被世界卫生组织批准为载脂蛋白A-I国际参考材料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号